ConvaTec Group PLC (CTEC.L) stock: key figures, P/E, revenue and dividend

Health Care · United Kingdom · ISIN GB00BD3VFW73

Price
3.11 GBP
Market cap
6.33 bn GBP
P/E (2025)
36.16
P/S (2025)
2.59
Dividend yield
2.35 %
Net margin
7.18 %
Return on equity (ROE)
11.53 %
Return on assets (ROA)
4.63 %

ConvaTec Group PLC financials

Fiscal year20242025
Revenue2.29 bn USD2.44 bn USD
Gross profit1.30 bn USD1.38 bn USD
Operating income352.00 m USD410.00 m USD
EBIT347.00 m USD399.00 m USD
Net income190.00 m USD175.00 m USD
Diluted EPS – continuing operations0.09 USD0.09 USD

Full history since 2009, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About ConvaTec Group PLC

Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, bladder cancer, inflammatory bowel disease, and trauma. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, neurological disease, prostate enlargement or other causes. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for use in continuous infusion treatments for conditions such as Parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. Convatec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 19.10.2026. Details in the risk notice.

ConvaTec Group PLC stock (CTEC.L): P/E, revenue, dividend | finmetric